SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales slipped to Rs. 1119.40 millions for the March 2022 quarter as against Rs. 1228.80 millions during the year-ago period.A slender decline of -7.84% was recorded to Rs. 290.20  millions from Rs. 314.90 millions in the corresponding previous quarter.A decline of 486.70 millions was observed in the OP in the quarter ended March 2022 from 506.40 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1119.40 1228.80 -8.90 5280.60 4826.80 9.40 5280.60 4826.80 9.40
Other Income 102.60 73.60 39.40 565.50 186.20 203.71 565.50 186.20 203.71
PBIDT 486.70 506.40 -3.89 2761.70 2325.50 18.76 2761.70 2325.50 18.76
Interest 0.20 0.30 -33.33 0.90 1.70 -47.06 0.90 1.70 -47.06
PBDT 486.50 506.10 -3.87 2760.80 2323.80 18.81 2760.80 2323.80 18.81
Depreciation 69.50 59.70 16.42 257.70 224.40 14.84 257.70 224.40 14.84
PBT 417.00 446.40 -6.59 2503.10 2099.40 19.23 2503.10 2099.40 19.23
TAX 126.80 131.50 -3.57 624.40 537.10 16.25 624.40 537.10 16.25
Deferred Tax 0.10 0.30 -66.67 8.20 -11.70 -170.09 8.20 -11.70 -170.09
PAT 290.20 314.90 -7.84 1878.70 1562.30 20.25 1878.70 1562.30 20.25
Equity 151.60 151.30 0.20 151.60 151.30 0.20 151.60 151.30 0.20
PBIDTM(%) 43.48 41.21 5.50 52.30 48.18 8.55 52.30 48.18 8.55

Caplin Point Lab Share Price

1772.50 6.05 (0.34%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×